| |
|
|
|
CASI Pharmaceuticals Inc.  
|
|
1.62 -0.12 (-0.07%) |
09-18 16:00 |
|
Open: |
1.76 |
Pre close: |
1.74 |
Target:
|
2.07 
|
|
High: |
1.76 |
Low: |
1.57 |
Resistance:
|
1.78
1.94
|
|
Volume: |
1,280,908 |
Market Cap: |
216M |
Support:
|
1.51
1.26
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.71
|
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
1.69 |
Signal(12,26,9): |
-0.08  |
|
MA(100): |
2.10 |
Stochastic Oscillator |
%K(14,3):
|
72.16 |
|
MA(250): |
2.47 |
%D(3): |
75.42 |
|
Average Volume(K) |
3-Month: |
51544
|
52-Week |
High:
|
3.67 |
|
10-Days: |
40050 |
Low: |
1.15 |
|
RSI |
RSI(14):
|
40.47 |
Change(%): |
-52.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.403 |
Return on Equity (ttm) |
-39.9 |
Shares Out. (M) |
123.94 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-22.3 |
Shares Float (M) |
77.81 |
|
EPS Est. Next Year |
-0.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
46.53 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.39 |
|
Forward EPS |
-0.320 |
Gross Profit (p.s.) |
0.002 |
Shares Short (K) |
1290 |
|
Book Value (p.s.) |
0.630 |
EBITDA (p.s.) |
-0.286 |
P/E |
-4.02 |
|
Sales Per Share |
0.082 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.57 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-20.59 |
P/S |
19.67 |
|
Operating Margin |
-364.84 |
Levered Free Cash Flow
(M) |
-23.35 |
P/CF |
-9.75 |
|
|
|
|
|
|
